Renal Cancer - Results from #5520

Renal cell carcinoma risk and obesity: A dose-response meta-analysis reveals another potential paradox within a paradox October 4, 2016

Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers October 3, 2016

Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs) October 3, 2016

Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma October 3, 2016

[Effect of Sunitinib therapy on immune function of patients with advanced renal cell carcinoma] October 3, 2016

Knockdown of serine-arginine protein kinase 1 inhibits the growth and migration in 6 renal cell carcinoma cells September 30, 2016

Sunitinib: the antiangiogenic effects and beyond September 30, 2016

Lymph Node Dissection Is Not Associated with Improved Survival Among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity-Score Based Analysis September 29, 2016

Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor September 29, 2016

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy September 28, 2016

Renal Cell Carcinoma Metastasized to Pagetic Bone September 28, 2016

Systematic review of renal carcinoma prognostic factors September 28, 2016

How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies? September 27, 2016

Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy September 26, 2016

Overexpression of functional SLC6A3 in clear cell renal cell carcinoma September 26, 2016

The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma September 26, 2016

Synchronous Type 1 Papillary Renal Cell Carcinoma in a Patient with Rectal Adenocarcinoma September 23, 2016

Treatment Outcome of Low-dose Interleukin-2 Therapy in Patients with Metastatic Renal Cell Carcinoma September 22, 2016

Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings September 21, 2016

Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale" September 21, 2016

Page 277 of 456